Pharmanutra S.p.A. (BIT:PHN)

Market Cap	782.29M +64.1%
Revenue (ttm)	132.16M +13.8%
Net Income	20.00M +20.4%
EPS	2.09 +20.6%
Shares Out	9.58M
PE Ratio	39.16
Forward PE	32.15
Dividend	1.20 (1.47%)
Ex-Dividend Date	May 5, 2025

Volume	1,059
Average Volume	26,945
Open	81.30
Previous Close	81.70
Day's Range	81.30 - 82.70
52-Week Range	38.75 - 82.80
Beta	0.11
RSI	70.17
Earnings Date	May 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for mu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 128
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2025, Pharmanutra's revenue was 132.16 million, an increase of 13.78% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.44%.